-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Maintains Speculative Buy on CapsoVision, Raises Price Target to $14

Benzinga·12/31/2025 14:17:32
Listen to the news
Benchmark analyst Bruce Jackson maintains CapsoVision (NASDAQ:CV) with a Speculative Buy and raises the price target from $5 to $14.